Does BEVACIZUMAB Cause Hepatic neoplasm? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Hepatic neoplasm have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.1% of all adverse event reports for BEVACIZUMAB.
49
Reports of Hepatic neoplasm with BEVACIZUMAB
0.1%
of all BEVACIZUMAB reports
13
Deaths
12
Hospitalizations
How Dangerous Is Hepatic neoplasm From BEVACIZUMAB?
Of the 49 reports, 13 (26.5%) resulted in death, 12 (24.5%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
RIBAVIRIN (49)
METFORMIN (47)
LOPERAMIDE (41)
Which BEVACIZUMAB Alternatives Have Lower Hepatic neoplasm Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ